3,484
Participants
Start Date
August 31, 2014
Primary Completion Date
November 30, 2014
Study Completion Date
April 30, 2015
Quadrivalent Influenza Vaccine (QIV)
One 0.5 mL intramuscular dose into the deltoid muscle
Trivalent Influenza Vaccine (TIV-1)
One 0.5 mL intramuscular dose into the deltoid muscle.
Trivalent Influenza Vaccine (TIV-2)
One 0.5 mL intramuscular dose into the deltoid muscle.
Site 285, Binghamton
Site 313, Rochester
Site 291, Rockville
Site 303, Charlottesville
Site 305, Winston-Salem
Site 306, Raleigh
Site 302, Charlotte
Site 309, Wilmington
Site 307, Mt. Pleasant
Site 292, Savannah
Site 297, Jacksonville
Site 293, Melbourne
Site 296, Huntsville
Site 308, Bristol
Site 311, Jefferson City
Site 312, Knoxville
Site 304, Knoxville
Site 295, Mishawaka
Site 294, Peoria
Site 287, St Louis
Site 317, Witchita
Site 316, Bellevue
Site 299, Oklahoma City
Site 282, Forth Worth
Site 288, San Angelo
Site 283, Austin
Site 289, Meridian
Site 300, Salt Lake City
Site 298, Las Vegas
Site 286, Los Angeles
Site 315, San Diego
Site 301, Milford
Site 310, Methuen
Seqirus
INDUSTRY